Pfizer invests in COLEY's TOXINS

Pharmaceuticals Coley Pharmaceutical Group, Inc. SnapshotPeople Company Overview Coley Pharmaceutical Group, Inc. operates as a biopharmaceutical company developing therapeutics and drug candidates that direct the human immune system to fight cancers, asthma and allergy, autoimmune disorders, and to enhance the effectiveness of vaccines. The company was formerly known as CpG ImmunoPharmaceuticals, Inc. and in August 2000 it changed its name to Coley Pharmaceutical Group, Inc. The company was founded in 1997 and is based in Wellesley, Massachusetts. As of December 28, 2007, Coley Pharmaceutical Group, Inc. operates as a subsidiary of Pfizer Inc. 93 Worcester Street Suite 101 Wellesley, MA 02481 United States Founded in 1997 150 Employees Phone: 781-431-9000 Fax: 781-431-6403 www.coleypharma.com Key Executives Dr. Robert L. Bratzler Chief Executive Officer Age: 62 Mr. Arthur Krieg Co-Founder Age: 51 Dr. Joachim Schorr Co-Founder Age: 49 Mr. Charles H. Abdalian Chief Financial Officer Age: 57 Dr. Christian Schetter Vice President of European Operations and Managing Director of Coley Pharmaceutical GmbH Age: 45

see http://kidney-renal-cancer.blogspot.com/2010/04/coleys-toxins-clinical-trial-frankfurt.html
CLINICAL TRIAL FRANKFURT Vaccineurin